Highlights from the European Society of Cardiology meeting and updates on radiopharmaceutical research
The newsletter reports that the European Society of Cardiology convened in Munich, with Europe correspondent Andrew Joseph providing coverage of the event.
The author contrasts the ESC’s rotating venues with those of the American Heart Association, noting past locations such as Madrid and Chicago and previewing future sites like Milan and Boston.
A brief note references the mental‑health system discussion following Lindsay Clancy’s work and mentions ongoing efforts to develop new radiopharmaceuticals.
The piece also muses that mRNA technology could soon be seen beyond vaccines, potentially playing a larger role in cancer therapies.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “A winner, a loser, and a mid-stage signal from a major cardiology research conference”
read at STAT ↗
comments(0)
5-min edit window · permanent after that